跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
SANDOZ RIVASTIGMINE PATCH 10
Authorized
STANDARD
SANDOZ RIVASTIGMINE PATCH 10
Sandoz Canada, Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b8429332d5af229d
Company
Sandoz Canada, Inc.
Type
Standard
Approval Details
Approval Id
b8429332d5af229d
Drug Approval Canada Name
SANDOZ RIVASTIGMINE PATCH 10
Product Name
SANDOZ RIVASTIGMINE PATCH 10
Status
Marketed
Status Date
2016-11-30
Original Market Date
2016-11-30
Din
02426307
Drug Class
Human
Dosage Form
Patch
Route Of Administration
Transdermal
Schedule
Prescription
Ahfs
12:04.00
Atc Original
N06DA03 RIVASTIGMINE
Atc Name
n 06 da 03
Aig Number
0140521008
Company Name
Sandoz Canada, Inc.
Company Address
4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path
/organization/sandoz-canada-inc
Company Information
Pharmaceutical Company Name
Sandoz Canada, Inc.
Country Name
Canada
Website
http://www.sandoz.ca
Active Ingredients
RIVASTIGMINE
9.5 MG / 24 HOUR
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b8429332d5af229d
Type
Standard
Back to Health Canada Approvals
SANDOZ RIVASTIGMINE PATCH 10 - Health Canada Drug Approval Details